# Nanome

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed September 25, 2026.

> Nanome is a collaborative workspace for drug discovery, offering molecular visualization and AI-powered tools for structural analysis, design, and team collaboration across web and XR (Virtual/Augmented Reality) platforms.

- Business Profile: https://optimly.ai/brand/nanome
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://nanome.ai/
- Logo: https://logo.clearbit.com/nanome.ai
- Slug: nanome
- Brand Authority Index tier: Contender
- Category: AI Drug Discovery & Development Platforms
- Last Analyzed: September 25, 2026

## Buyer Intent Signals
Problems: Slow traditional drug discovery workflows | Inefficient structural analysis and molecular design | Lack of real-time collaboration for remote R&D teams | Limitations of desktop-only molecular viewers (e.g., script-driven nature, no native XR, no AI copilot) | Difficulty in conveying complex 3D structural information
Solutions: Collaborative molecular visualization | AI-powered drug discovery and molecular design | Real-time structural analysis and optimization | XR/VR/AR for immersive molecular interaction | Conversational interface for data interaction (MARA AI copilot) | Integration with existing scientific tools and databases (e.g., Schrödinger LiveDesign, CDD Vault, AlphaFold DB) | Streamlining drug discovery pipelines
Comparisons: Comparing Nanome with PyMOL or other molecular viewers | Assessing the benefits of XR/VR/AR in drug discovery | Evaluating AI tools for molecular design and analysis | Reviewing collaborative features for remote R&D teams | Checking supported VR/AR headsets | Looking for case studies and publications